An increasing number of individuals are being exposed to iodinated contrast media (CM). This derives from both the technical advances that have enhanced the role of imaging in the diagnostic and therapeutic arena and the changing demographics of the population. There are more elderly individuals with a burden of chronic diseases including hypertension, diabetes, kidney disease and heart disease, for which the tools of the radiologist and interventionalist are particularly appropriate. It is therefore not surprising that increasing attention in the medical literature is being given to the renal adverse effect of CM, contrast-induced nephropathy (CIN) and strategies to minimize its incidence.